Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression.

Schmidt G, Meyberg-Solomayer G, Gerlinger C, Juhasz-Böss I, Herr D, Rody A, Liedtke C, Solomayer E (2014)
In: Archives of Gynecology and Obstetrics, 290(6)
Art der Publikation: Forschungsartikel (Zeitschrift)

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

Karn T, Pusztai L, Ruckhäberle E, Liedtke C, Müller V, Schmidt M, Metzler D, Wang J, Coombes KR, Gätje R, Hanker L, Solbach C, Ahr A, Holtrich U, Rody A, Kaufmann M (2012)
In: European Journal of Cancer, 48(1)
Art der Publikation: Forschungsartikel (Zeitschrift)

Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer.

Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L (2012)
In: Annals of Surgical Oncology, 19(5)
Art der Publikation: Forschungsartikel (Zeitschrift)

Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial.

Gluz O, Wild P, Liedtke C, Kates R, Mendrik H, Ehm E, Artinger V, Diallo-Danebrock R, Ting E, Mohrmann S, Poremba C, Harbeck N, Nitz U, Hartmann A, Gaumann A (2011)
In: Breast Cancer Research and Treatment, 126(3)
Art der Publikation: Forschungsartikel (Zeitschrift)

Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer.

Liedtke C, Kiesel L (2011)
In: Breast Care, 6(3)
Art der Publikation: Forschungsartikel (Zeitschrift)

Publikationen

Kontakt

Top-Links

Identification of prognostic different subgroups in triple negative breast cancer by Her2-neu protein expression. Schmidt G, Meyberg-Solomayer G, Gerlinger C, Juhasz-Böss I, Herr D, Rody A, Liedtke C, Solomayer E (2014) In: Archives of Gynecology and Obstetrics, 290(6) Art der Publikation: Forschungsartikel (Zeitschrift)
Nomogramme zur Prädiktion von non-Sentinellymphknoten-(SLN)-Metastasen nach primär systemischer Therapie (PST)--die transSENTINA Substudie Liedtke C, Görlich D, Van Zee K, Korndörfer J, Bauerfeind I, Fehm T, Fleige B, Helms G, Lebeau A, Staebler A, von Minckwitz G, Untch M, Kühn T (2013) In: 33. Jahrestagung der Deutschen Gesellschaft für Senologie, München, . Art der Publikation: Abstract in Online-Sammlung (Konferenz)
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation. Karn T, Pusztai L, Ruckhäberle E, Liedtke C, Müller V, Schmidt M, Metzler D, Wang J, Coombes KR, Gätje R, Hanker L, Solbach C, Ahr A, Holtrich U, Rody A, Kaufmann M (2012) In: European Journal of Cancer, 48(1) Art der Publikation: Forschungsartikel (Zeitschrift)
Targeting triple-negative breast cancer by conversion into HER2-positive cancer: A novel therapeutic approach. Bernemann C, Huelsewig C, Kiesel L, Liedtke C (2012) In: Journal of Clinical Oncology, 30 S(15) Art der Publikation: Forschungsartikel (Zeitschrift)
Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, Denkert C, Eiermann W, Gnant M, Harris JR, Karn T, Liedtke C, Mauri D, Rouzier R, Ruckhaeberle E, Semiglazov V, Symmans WF, Tutt A, Pusztai L (2012) In: Annals of Surgical Oncology, 19(5) Art der Publikation: Forschungsartikel (Zeitschrift)
Systematic analysis of in vitro chemosensitivity and mib-1 expression in molecular breast cancer subtypes. Liedtke C, Packeisen J, Hess KR, Vogt U, Kiesel L, Kersting C, Korsching E, Brandt B, Buerger H (2012) In: European Journal of Cancer, 48(13) Art der Publikation: Forschungsartikel (Zeitschrift)
Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial. Gluz O, Wild P, Liedtke C, Kates R, Mendrik H, Ehm E, Artinger V, Diallo-Danebrock R, Ting E, Mohrmann S, Poremba C, Harbeck N, Nitz U, Hartmann A, Gaumann A (2011) In: Breast Cancer Research and Treatment, 126(3) Art der Publikation: Forschungsartikel (Zeitschrift)
News from the San Antonio Breast Cancer Symposium 2010 Konecny GE, Fehm T, Liedtke C, Kiesel L, Loibl S, Miller KD (2011) In: Breast Care, 6(1) Art der Publikation: Forschungsartikel (Zeitschrift)
Current Issues of Targeted Therapy in Metastatic Triple-Negative Breast Cancer. Liedtke C, Kiesel L (2011) In: Breast Care, 6(3) Art der Publikation: Forschungsartikel (Zeitschrift)
THE WNT SIGNALING CASCADE AS A POTENTIAL NOVEL BIOMARKER OF TRIPLE NEGATIVE BREAST CANCER (TNBC) Huelsewig C, Ruckert C, Goette M, von Wahlde MK, Buchweitz O, Kiesel L, Pusztai L, Liedtke C (2011) In: Annals of Oncology, 22 Art der Publikation: Forschungsartikel (Zeitschrift)